Results 51 to 60 of about 2,813 (193)

Oligometastatic Head and Neck Cancer: Challenges and Perspectives

open access: yes, 2022
SIMPLE SUMMARY: Oligometastasis represents a disease state and an opportunity for cure when metastases emerge. Emerging evidence supports that most head and neck cancer patients with oligometastatic disease are likely to benefit from curative intent ...
Shao Hui Huang   +5 more
core   +1 more source

Validation of the 9th Edition of the Tumor‐Node‐Metastasis Staging System for Non‐Metastatic Nasopharyngeal Carcinoma: A Multicenter Retrospective Analysis From High‐Incidence Regions

open access: yesCancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Objective To evaluate and compare the prognostic value of the 8th and 9th editions of the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system in patients with non‐metastatic nasopharyngeal carcinoma (NPC).
Yongquan Wei   +12 more
wiley   +1 more source

Research Progress and Challenges of Oligometastasis in Non-small Cell Lung Cancer

open access: yesChinese Journal of Lung Cancer
Oligometastasis represents a transitional state between early localized disease and widespread metastasis, characterized by limited tumor burden and distinct tumor biological behavior.
Songzhen LI, Tianhang SHAO, Shuyang YAO
doaj   +1 more source

Successful Multidisciplinary Treatment with Laparoscopic Hepatectomy and Adjuvant Therapy for Metachronous Solitary Hepatic Metastasis after Excision of a Primary Anorectal Malignant Melanoma: A Case Report

open access: yesCurrent Oncology, 2023
Anorectal malignant melanoma (ARMM) is extremely rare and generally lethal, irrespective of the treatment administered. The disease is often diagnosed late, metastases being present in approximately two-thirds of patients at the time of initial diagnosis.
Ryotaro Shimazaki   +10 more
doaj   +1 more source

Early Local Treatment Delays Multiple Metastases in Non‐Small Cell Lung Cancer With Solitary Distant Metastasis: A Multicenter Retrospective Cohort Study

open access: yesMedComm, Volume 7, Issue 9, September 2026.
In NSCLC patients with solitary distant metastasis (SDM), early local treatment significantly delays the progression to multi‐metastasis by 14 months (HR = 0.55) compared to delayed or no treatment. This multicenter cohort study highlights SDM as an indolent state, emphasizing the critical time window for effective local intervention. .
Kang Miao   +10 more
wiley   +1 more source

DataSheet_1_Assessment of oligometastasis status of prostate cancer following combined robot-assisted radical prostatectomy and androgen deprivation versus androgen deprivation therapy alone using PSA percentage decline rate.xlsx

open access: yes, 2023
ObjectiveTo compare the tumor control in prostate cancer patients with oligo-metastasis following combined robot-assisted radical prostatectomy and androgen deprivation versus androgen deprivation therapy alone based on total prostate-specific antigen ...
Cheng Zhang (70708)   +6 more
core   +1 more source

Management of Non-Small Cell Lung Cancer with Oligometastasis [PDF]

open access: yesCurrent Oncology Reports, 2012
Patients with oligometastatic Non-Small Cell Lung Cancer (NSCLC) present a potential opportunity for curative therapy; however, the challenge remains the definitive treatment of their localized disease and ablation of their limited overt metastatic sites of disease. In selecting patients with oligometastatic NSCLC for definitive therapy, proper staging
Liza C, Villaruz   +2 more
openaire   +2 more sources

Stereotactic Body Radiation Therapy for the Treatment of Locally Recurrent and Oligoprogressive Non-Small Cell Lung Cancer: A Single Institution Experience

open access: yesFrontiers in Oncology, 2022
ObjectivesTo investigate the efficacy and safety of lung stereotactic body radiation therapy (SBRT) for non-small cell lung cancer (NSCLC) including oligorecurrent and oligoprogressive disease.MethodsSingle-institution retrospective analysis of 60 NSCLC ...
Leah M. Katz   +10 more
doaj   +1 more source

Concurrent Stereotactic Radiotherapy and Immune Checkpoint Inhibitors for Multiple Brain Metastases in Non‐Small Cell Lung Cancer ‐ A Multi‐Center Retrospective Analysis

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 8, August 2026.
Initiating ICIs within 14 days post SRT, especially at a short interval after radiotherapy, markedly extends OS and iPFS, with no elevated risks of RN or adverse events. ABSTRACT Background This study aimed to evaluate the efficacy and safety of concurrent versus sequential stereotactic radiotherapy (SRT) and immune checkpoint inhibitors (ICIs) in non ...
Xiaoliang Wang   +6 more
wiley   +1 more source

A case of discordant histology and expression of programmed death ligand 1 between primary tumor and brain metastases in adenosquamous carcinoma of the lung

open access: yesThoracic Cancer, 2023
A patient presented with vomiting and gait disturbance. Investigation revealed a single cerebellar tumor and another tumor in the upper lobe of the left lung.
Hironori Takagi   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy